The number of people with susceptibility test result for rifampicin in El Salvador
El Salvador: The number of people with susceptibility test result for rifampicin was 316 in 2021. ▼ Falling
Latest (2021)
316
Change on year
down 39.3%
World rank
87th
of 155 countries
All-time high
1,193
in 2017
All-time low
316
in 2021
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in El Salvador, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in El Salvador is 316, measured in 2021. That is the lowest value across all 5 years on record.
Compared with earlier readings it is down 39.3% on the previous year and down 73.5% over five years.
That places El Salvador 87th out of 155 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in El Salvador, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 1,193 | — |
| 2018 | 819 | -31.3% |
| 2019 | 521 | -36.4% |
| 2020 | 521 | +0.0% |
| 2021 | 316 | -39.3% |
El Salvador compared with similar countries
- El Salvador's 316 is below the median for upper middle income countries, which is 880, 36% of the median. (46 countries reporting)
- El Salvador's 316 is below the median for Latin America & Caribbean, which is 406.5, 78% of the median. (26 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 844.33 | 521 | 1,193 | 3 |
| 2020s | 418.5 | 316 | 521 | 2 |
Countries ranked near El Salvador
More health data for El Salvador
- Un projection of annual infant deaths, annual growth rate -1.89 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4574 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,537 deaths per 1,000 people (2090)
- Number of infants who die before age 1 104 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.9135 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0374 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.8849 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in El Salvador?
- The number of people with susceptibility test result for rifampicin in El Salvador was 316 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in El Salvador?
- The highest recorded value was 1,193 in 2017.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in El Salvador?
- The lowest recorded value was 316 in 2021.
- How does El Salvador rank for the number of people with susceptibility test result for rifampicin?
- El Salvador ranks 87th out of 155 countries with data for 2021.
- Where does this El Salvador data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).